The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stratmann, T.
Right arrow Articles by Teyton, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stratmann, T.
Right arrow Articles by Teyton, L.
The Journal of Immunology, 00, 165: 3214-3225.
Copyright © 00 by The American Association of Immunologists

The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder1

Thomas Stratmann*, Vasso Apostolopoulos{ddagger}, Valérie Mallet-Designe*, Adam L. Corper{ddagger}, Christopher A. Scott2,{ddagger}, Ian A. Wilson{ddagger}, Angray S. Kang3,{ddagger} and Luc Teyton4,*

Departments of * Immunology and {dagger} Molecular Biology, and {ddagger} The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037

Susceptibility to insulin-dependent diabetes mellitus is linked to MHC class II genes. The only MHC class II molecule expressed by nonobese diabetic (NOD) mice, I-Ag7, shares a common {alpha}-chain with I-Ad but has a peculiar ß-chain. As with most ß-chain alleles linked to diabetes susceptibility, I-Ag7 contains a nonaspartic residue at position ß57. We have produced large amounts of empty I-Ag7 molecules using a fly expression system to characterize its biochemical properties and peptide binding by phage-displayed peptide libraries. The identification of a specific binding peptide derived from glutamic acid decarboxylase (GAD65) has allowed us to crystallize and obtain the three-dimensional structure of I-Ag7. Structural information was critical in evaluating the binding studies. I-Ag7, like I-Ad, appears to be very promiscuous in terms of peptide binding. Their binding motifs are degenerate and contain small and/or small hydrophobic residues at P4 and P6 of the peptide, a motif frequently found in most globular proteins. The degree of promiscuity is increased for I-Ag7 over I-Ad as a consequence of a larger P9 pocket that can specifically accommodate negatively charged residues, as well as possibly residues with bulky side chains. So, although I-Ad and I-Ag7 are structurally closely related, stable molecules and good peptide binders, they differ functionally in their ability to bind significantly different peptide repertoires that are heavily influenced by the presence or the absence of a negatively charged residue at position 57 of the ß-chain. These characteristics link I-Ag7 with autoimmune diseases, such as insulin-dependent diabetes mellitus.




This article has been cited by other articles:


Home page
JEMHome page
N. Ishimaru, R. Arakaki, S. Yoshida, A. Yamada, S. Noji, and Y. Hayashi
Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy
J. Exp. Med., November 24, 2008; 205(12): 2915 - 2927.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Tian, M. J. I. Ansari, J. Paez-Cortez, J. Bagley, J. Godwin, M. Donnarumma, M. H. Sayegh, and J. Iacomini
Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy
J. Immunol., November 15, 2007; 179(10): 6762 - 6769.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Gardiner, K. A. Richards, A. J. Sant, and L. S. Arneson
Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide
Int. Immunol., September 1, 2007; 19(9): 1103 - 1113.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue
The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form
J. Immunol., May 15, 2007; 178(10): 6051 - 6057.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff
Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes
J. Immunol., December 1, 2006; 177(11): 7588 - 7598.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Bill, D. G. Mack, M. T. Falta, L. A. Maier, A. K. Sullivan, F. G. Joslin, A. K. Martin, B. M. Freed, B. L. Kotzin, and A. P. Fontenot
Beryllium Presentation to CD4+ T Cells Is Dependent on a Single Amino Acid Residue of the MHC Class II {beta}-Chain
J. Immunol., November 15, 2005; 175(10): 7029 - 7037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Smith, T. Patterson, and M. E. Pauza
Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes
J. Immunol., April 1, 2005; 174(7): 3897 - 3905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Carven, S. Chitta, I. Hilgert, M. M. Rushe, R. F. Baggio, M. Palmer, J. E. Arenas, J. L. Strominger, V. Horejsi, L. Santambrogio, et al.
Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding
J. Biol. Chem., April 16, 2004; 279(16): 16561 - 16570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zavala-Ruiz, E. J. Sundberg, J. D. Stone, D. B. DeOliveira, I. C. Chan, J. Svendsen, R. A. Mariuzza, and L. J. Stern
Exploration of the P6/P7 Region of the Peptide-binding Site of the Human Class II Major Histocompatability Complex Protein HLA-DR1
J. Biol. Chem., November 7, 2003; 278(45): 44904 - 44912.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-H. Jang, N. P. Seth, and K. W. Wucherpfennig
Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors
J. Immunol., October 15, 2003; 171(8): 4175 - 4186.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Jaeckel, L. Klein, N. Martin-Orozco, and H. von Boehmer
Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase
J. Exp. Med., June 16, 2003; 197(12): 1635 - 1644.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Cantu III, K. Benlagha, P. B. Savage, A. Bendelac, and L. Teyton
The Paradox of Immune Molecular Recognition of {alpha}-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for {alpha}{beta} TCRs
J. Immunol., May 1, 2003; 170(9): 4673 - 4682.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Suri, J. J. Walters, O. Kanagawa, M. L. Gross, and E. R. Unanue
Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition
PNAS, April 29, 2003; 100(9): 5330 - 5335.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz
Directed evolution of a single-chain class II MHC product by yeast display
Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette
The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity
J. Immunol., November 1, 2002; 169(9): 5098 - 5108.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt
CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer
J. Exp. Med., August 19, 2002; 196(4): 481 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Wen, F. S. Wong, R. Sherwin, and C. Mora
Human DQ8 Can Substitute for Murine I-Ag7 in the Selection of Diabetogenic T Cells Restricted to I-Ag71
J. Immunol., April 1, 2002; 168(7): 3635 - 3640.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Suri, I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, and E. R. Unanue
In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket
J. Immunol., February 1, 2002; 168(3): 1235 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. Monneaux, H. Dumortier, G. Steiner, J.-P. Briand, and S. Muller
Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZB NZW)F1 lupus mice
Int. Immunol., September 1, 2001; 13(9): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Kelemen, D. R. Wegmann, and J. C. Hutton
T-Cell Epitope Analysis on the Autoantigen Phogrin (IA-2{beta}) in the Nonobese Diabetic Mouse
Diabetes, August 1, 2001; 50(8): 1729 - 1734.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.